How can stronger relationships be built between sponsors and CROs? How can sharing trial data improve trial outcomes? What are the best ways to measure performance and conduct between sponsor and CRO?
In light of ICH E6(R2) guidelines, sponsors and CROs are reviewing how well they work together. This webinar presents a detailed look at the performance of sponsor/CRO-driven studies.
Karen McCarthy Schau of Paragon—a leading consulting firm that helps health and life sciences companies become high-performing, compliant, and digitally connected—focuses the discussion on three key strategies:
- Assessing alignment with guidelines
- Benefits of risk-based oversight
- Automation advantages
